184 related articles for article (PubMed ID: 11242650)
1. [A case of lung and pleural metastases from breast cancer responding to toremifene].
Inoue K; Tabei T; Kusawake T; Sugamata N; Suemasu K; Higashi Y; Kurosumi M
Gan To Kagaku Ryoho; 2001 Feb; 28(2):221-4. PubMed ID: 11242650
[TBL] [Abstract][Full Text] [Related]
2. [A breast cancer patient with recurrence in the thoracic wall in whom a high-dose of toremifene was effective].
Ishida K; Mori H; Fujii T; Kawashima K; Hanaoka T; Mihara Y
Gan To Kagaku Ryoho; 2001 Feb; 28(2):225-8. PubMed ID: 11242651
[TBL] [Abstract][Full Text] [Related]
3. [A case of breast cancer patient of CAF (cyclophosphamide, adriamycin, 5-fluorouracil) resistant lung metastasis with remarkable response to reverse drug-resistance by toremifene].
Kusama M; Kaise H; Nakayama S; Ohta D; Aoki T; Koyanagi Y
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1171-5. PubMed ID: 10431584
[TBL] [Abstract][Full Text] [Related]
4. [A case of metastatic breast cancer responding to weekly paclitaxel and high-dose toremifene administrated alternately].
Murakami H; Noda S; Okamura Y; Sakakibara T; Ishikawa T; Nakamura H; Yaguchi T; Harada A
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1963-6. PubMed ID: 12465396
[TBL] [Abstract][Full Text] [Related]
5. [A case of breast cancer with multiple bone metastases improved by high-dose toremifene].
Doi T; Nishiyama K; Wakasugi J; Ootaki S; Kikuchi M; Kubota K; Yamamoto H
Gan To Kagaku Ryoho; 2001 Jun; 28(6):839-43. PubMed ID: 11432355
[TBL] [Abstract][Full Text] [Related]
6. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
Saito Y; Amano S; Kashio M; Abe H; Kuboi Y; Sakurai K; Aoki N; Hata S; Negishi N
Gan To Kagaku Ryoho; 2004 Jun; 31(6):911-4. PubMed ID: 15222111
[TBL] [Abstract][Full Text] [Related]
7. [Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer].
Yamamoto Y; Kawazoe T; Iwase H
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1415-9. PubMed ID: 16227740
[TBL] [Abstract][Full Text] [Related]
8. [A case of postoperative lung and pleural recurrence after 20 years in a breast cancer patient with marked response to orally administered UFT and cyclophosphamide].
Kusama M; Kaise H; Nakayama S; Oota D; Aoki T; Koyanagi Y; Matsunaga T; Nakamura Y
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1573-6. PubMed ID: 11016004
[TBL] [Abstract][Full Text] [Related]
9. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients.
Cappelletti V; Celio L; Bajetta E; Allevi A; Longarini R; Miodini P; Villa R; Fabbri A; Mariani L; Giovanazzi R; Galante E; Greco M; Grazia Daidone M
Endocr Relat Cancer; 2004 Dec; 11(4):761-70. PubMed ID: 15613450
[TBL] [Abstract][Full Text] [Related]
11. [Hormone therapy of advanced renal cancer with high-dose toremifene (Fareston)].
Gershanovich ML; Moiseenko VM; Vorob'ev AV; Kiapiulia K
Vopr Onkol; 1996; 42(5):105-9. PubMed ID: 9064893
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer].
Koyama H; Iesato A; Fukushima Y; Okada T; Watanabe T; Harada M; Ito T; Maeno K; Mochizuki Y; Ito K; Amano J
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1123-6. PubMed ID: 21772095
[TBL] [Abstract][Full Text] [Related]
13. [A case of aromatase inhibitor-tolerant metastatic breast cancer revealing complete remission with high-dose toremifene therapy].
Kurozumi S; Takeo T; Ikeda F; Horiguchi J; Takeyoshi I; Ito H
Gan To Kagaku Ryoho; 2011 Jan; 38(1):93-6. PubMed ID: 21368465
[TBL] [Abstract][Full Text] [Related]
14. [A case of aged recurrent breast cancer with multiple lung metastases responding to examestane monotherapy].
Imamura S; Aso M; Sakata H; Katoh H
Gan To Kagaku Ryoho; 2006 Mar; 33(3):361-4. PubMed ID: 16531719
[TBL] [Abstract][Full Text] [Related]
15. Toremifene: an evaluation of its safety profile.
Harvey HA; Kimura M; Hajba A
Breast; 2006 Apr; 15(2):142-57. PubMed ID: 16289904
[TBL] [Abstract][Full Text] [Related]
16. [A study of the efficacy of high-dose toremifene in advanced and recurrent breast cancer].
Tokura H; Fujisaki M; Takahashi T; Takigawa Y; Onouchi S; Matsuda K; Hirata A
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1071-3. PubMed ID: 22790041
[TBL] [Abstract][Full Text] [Related]
17. Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial.
Nicolini A; Carpi A
Biomed Pharmacother; 2005 Jun; 59(5):253-63. PubMed ID: 15913946
[TBL] [Abstract][Full Text] [Related]
18. Primary toremifene treatment for elderly postmenopausal women with breast cancer.
Hamada N; Ogawa Y; Nishioka A; Kariya S; Yoshida S
Oncol Rep; 2004 Feb; 11(2):365-70. PubMed ID: 14719069
[TBL] [Abstract][Full Text] [Related]
19. [Plasma concentrations of toremifene citrate and N-desmethyltoremifene in postmenopausal patients with breast cancer--comparison of 120 mg of toremifene citrate administered once a day and divided into 3 separate doses (t.i.d.)].
Shiba E; Watanabe T; Taguchi T; Tsukamoto F; Noguchi S
Gan To Kagaku Ryoho; 2000 Feb; 27(2):245-9. PubMed ID: 10700895
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors].
Ohtake T; Yasuda M; Watanabe K; Ito T; Ito J; Miyamoto K; Yoshida S; Abe N; Ishigame T; Ishii M; Kimijima I; Takenoshita S
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1459-63. PubMed ID: 19755813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]